FDA approves blood test method for colon cancer screening

The FDA approved Guardant Health's Shield blood test for colon cancer screening, making it likely to be covered by Medicare and private insurers. It is effective at detecting later-stage cancers but not early-stage polyps. A positive result requires follow-up with a colonoscopy. Doctors see potential for increased screening rates, but its impact on reducing mortality remains to be seen.

from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/QlbLDMO

Comments

Popular posts from this blog

JEE Main 2022 session 2 correction window closes today at jeemain.nta.nic.in, check direct link

Ukraine says talks on France sending military instructors still ongoing

Ukraine officer had key role in Nord Stream sabotage: Reports